Tender

Delivery of MenACWY vaccines to 19-25 year-old students in London during September 2017

N E L COMMISSIONING SUPPORT UNIT

This public procurement record has 1 release in its history.

Tender

25 Aug 2017 at 15:33

Tender Notice
Summary of the contracting process

The N E L Commissioning Support Unit is conducting a tender for the delivery of MenACWY vaccines to 19-25 year-old students in London during September 2017. This procurement, classified under health services, is set in London and follows an AQP process for a short-term contract under NHS Standard Contract 2017/18 terms. The tender period ends on 1 September 2017, with the contract commencing on 18 September 2017 and lasting until 31 October 2017. Interested qualified providers must register via the ProContract portal and submit their completed questionnaires by the specified deadline. Activity will be reimbursed at a standard London region price of £9.80 per vaccination.

This tender presents a significant opportunity for businesses involved in healthcare services, particularly those specialising in vaccination delivery. Small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) are encouraged to participate, as they may leverage their agility and local knowledge to effectively meet the health needs of the targeted demographic. By successfully securing this contract, providers can enhance their visibility in the healthcare sector while contributing to public health initiatives aimed at combating meningococcal disease among young adults.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Delivery of MenACWY vaccines to 19-25 year-old students in London during September 2017

Notice Description

London Region is looking for any existing qualified providers to deliver MenACWY vaccine to 19-25 year old students during September 2017. London's community pharmacies are exempt from this procurement process since they will apply and be processed via SONAR platform as a Contract Variation to their Core Contract. MenACWY vaccine was introduced in 2015 to respond to a rapid and accelerating increase in cases of invasive meningococcal group W (MenW) disease, which had been declared a national incident. The MenACWY conjugate vaccine provides direct protection to the vaccinated cohort and, by reducing MenW carriage, will also provide indirect protection to unvaccinated children and adults. This follows advice from the Joint Committee on Vaccination and Immunisation (JCVI). This commission is for September - October 2017 only. This contract period is an estimation as there is a stock of 15,000 additional vaccines ordered for this purpose and this AQP service will run until this central stock of vaccines has been exhausted. Any Qualified Provider seeking authorisation to proceed should register an interest in this opportunity via the ProContract portal, complete the online questionnaire and submit this completed questionnaire before the stated submission deadline of 17.00 on Friday 1 September 2017. Activity will be reimbursed at the standard London region price of PS9.80 per vaccination for MenACWY 19-25. No further payment is provided as part of this service delivery. This procurement is being conducted as an AQP process for a short-term time limited contract under the NHS Standard Contract 2017/18 terms and conditions. The services to which this procurement relate fall under Schedule 3 of the Public Contracts Regulations (PCR) 2015 and, as such, NHS England do not intend to hold themselves bound to any of the PCR regulations save those applicable to services procured under the "Light Touch Regime". Additional information: https://procontract.due-north.com/Advert?advertId=0ccc9fa6-be88-e711-80e4-005056b64545 Meningococcal disease is a bacteria infection caused by Neisseria meningitides. There are 12 identified capsular groups and Men ACWY protects against 4 of the most common. Between 5-11% of adults and up to 25% of adolescents carry the bacteria and carriage rate is low in infants and young children. Transmission is by aerosol, droplets or direct contact with respiratory secretions of someone carrying the organism. It is not clear why disease develops in some people and not others. The latest annual trend data is for 2015/16 and this demonstrated in increase of 11% in Invasive Meningococcal Disease (IMD) from 724 cases in 2014/15 to 805. (Overall IMD rates are declining since 1999/2000 due to the successful Men C and Men B vaccination programmes in childhood). Since 2009, Men W is on the rise and accounted for 25% of cases reported in 2015/16, increasing by 19% from 176 in 2014/15. Numbers of Men W cases were the highest seen since records started in the 1990s and the increase is attributed to the increase to of the hyper virulent Men W clonal complex 11 (cc11) which is not associated with travel and is seen predominately in adolescents, whom contributed 17% of the cases. Men W causes 4 deaths annually and in 2016, there was a death in a first year university student ('fresher') in North East London.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-2c8bcf55-05ed-4750-aaeb-36efd339eaf5
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/854f305f-70c6-428f-b346-6c6ae2d86237
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
25 Aug 20178 years ago
Submission Deadline
1 Sep 2017Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
17 Sep 2017 - 31 Oct 2017 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
N E L COMMISSIONING SUPPORT UNIT
Contact Name
Barend Henning
Contact Email
barend.henning@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
SE1 6LH
Post Town
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
TLI London
Local Authority
Southwark
Electoral Ward
St George's
Westminster Constituency
Bermondsey and Old Southwark

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-2c8bcf55-05ed-4750-aaeb-36efd339eaf5-2017-08-25T16:33:51+01:00",
    "date": "2017-08-25T16:33:51+01:00",
    "ocid": "ocds-b5fd17-2c8bcf55-05ed-4750-aaeb-36efd339eaf5",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "RTL084P",
        "title": "Delivery of MenACWY vaccines to 19-25 year-old students in London during September 2017",
        "description": "London Region is looking for any existing qualified providers to deliver MenACWY vaccine to 19-25 year old students during September 2017. London's community pharmacies are exempt from this procurement process since they will apply and be processed via SONAR platform as a Contract Variation to their Core Contract. MenACWY vaccine was introduced in 2015 to respond to a rapid and accelerating increase in cases of invasive meningococcal group W (MenW) disease, which had been declared a national incident. The MenACWY conjugate vaccine provides direct protection to the vaccinated cohort and, by reducing MenW carriage, will also provide indirect protection to unvaccinated children and adults. This follows advice from the Joint Committee on Vaccination and Immunisation (JCVI). This commission is for September - October 2017 only. This contract period is an estimation as there is a stock of 15,000 additional vaccines ordered for this purpose and this AQP service will run until this central stock of vaccines has been exhausted. Any Qualified Provider seeking authorisation to proceed should register an interest in this opportunity via the ProContract portal, complete the online questionnaire and submit this completed questionnaire before the stated submission deadline of 17.00 on Friday 1 September 2017. Activity will be reimbursed at the standard London region price of PS9.80 per vaccination for MenACWY 19-25. No further payment is provided as part of this service delivery. This procurement is being conducted as an AQP process for a short-term time limited contract under the NHS Standard Contract 2017/18 terms and conditions. The services to which this procurement relate fall under Schedule 3 of the Public Contracts Regulations (PCR) 2015 and, as such, NHS England do not intend to hold themselves bound to any of the PCR regulations save those applicable to services procured under the \"Light Touch Regime\". Additional information: https://procontract.due-north.com/Advert?advertId=0ccc9fa6-be88-e711-80e4-005056b64545 Meningococcal disease is a bacteria infection caused by Neisseria meningitides. There are 12 identified capsular groups and Men ACWY protects against 4 of the most common. Between 5-11% of adults and up to 25% of adolescents carry the bacteria and carriage rate is low in infants and young children. Transmission is by aerosol, droplets or direct contact with respiratory secretions of someone carrying the organism. It is not clear why disease develops in some people and not others. The latest annual trend data is for 2015/16 and this demonstrated in increase of 11% in Invasive Meningococcal Disease (IMD) from 724 cases in 2014/15 to 805. (Overall IMD rates are declining since 1999/2000 due to the successful Men C and Men B vaccination programmes in childhood). Since 2009, Men W is on the rise and accounted for 25% of cases reported in 2015/16, increasing by 19% from 176 in 2014/15. Numbers of Men W cases were the highest seen since records started in the 1990s and the increase is attributed to the increase to of the hyper virulent Men W clonal complex 11 (cc11) which is not associated with travel and is seen predominately in adolescents, whom contributed 17% of the cases. Men W causes 4 deaths annually and in 2016, there was a death in a first year university student ('fresher') in North East London.",
        "datePublished": "2017-08-25T16:33:51+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "procurementMethodDetails": "Not specified",
        "tenderPeriod": {
            "endDate": "2017-09-01T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2017-09-18T00:00:00+01:00",
            "endDate": "2017-10-31T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": true
        },
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/854f305f-70c6-428f-b346-6c6ae2d86237",
                "datePublished": "2017-08-25T16:33:51+01:00",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "biddingDocuments",
                "url": "https://procontract.due-north.com/Advert?advertId=0ccc9fa6-be88-e711-80e4-005056b64545"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/m4hc8Tk6",
            "name": "N E L COMMISSIONING SUPPORT UNIT",
            "identifier": {
                "legalName": "N E L COMMISSIONING SUPPORT UNIT",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/m4hc8Tk6"
            },
            "address": {
                "streetAddress": "80 London Road",
                "locality": "London",
                "postalCode": "SE1 6LH",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Barend Henning",
                "email": "barend.henning@nhs.net"
            },
            "details": {
                "url": "https://procontract.due-north.com/Advert?advertId=0ccc9fa6-be88-e711-80e4-005056b64545"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/m4hc8Tk6",
        "name": "N E L COMMISSIONING SUPPORT UNIT"
    }
}